Tonix Pharmaceuticals Holding Corp

Financials

Flusso di cassa derivante dalle attività operative -14.63 M-16.58 M-14.83 M-28.78 M-39.65 M -99.84 M Flussi di cassa derivanti dalle attività di investimento -3 000-6 000-2.54 M-962 K-1.02 M -4.53 M Liquidità derivante dalle attività di finanziamento 85.15 M49.53 M10.99 M94.86 M59.14 M 214.53 M Liquidità libera -14.63 M-16.59 M-15.36 M-29.74 M-41.52 M -103.21 M

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

TNXP

Financials

Tonix Pharmaceuticals Holding Corp

Notizie

Tonix pubblica studio farmacocinetico sul farmaco per la fibromialgia

Il CEO di Tonix Pharma Lederman acquista azioni per 63.099$

Tonix pianifica studio di Fase 2 sulla prevenzione della malattia di Lyme nel 2027

Tonix Pharmaceuticals Holding Corp. (TNXP) Presents at BIO-Europe Spring 2026 - Slideshow (NASDAQ:TNXP) 2026-03-25

Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch - Tonix Pharmaceuticals (NASDAQ:TNXP)

Gli EPS di Tonix Pharma hanno mancato le aspettative per 0,79$, il fatturato supera le previsioni

Tonix Pharma earnings missed by $0.79, revenue topped estimates

Tonix presenta dati sul farmaco per la fibromialgia alla conferenza in Polonia

Tonix presents fibromyalgia drug data at Poland conference

Tonix Pharmaceuticals passa al Nasdaq Global Select Market

Tonix Pharmaceuticals moves to Nasdaq Global Select Market

Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting - Tonix Pharmaceuticals (NASDAQ:TNXP)